Three dimensional quantitative structure-activity relationship of farnesyl protein transferase inhibitors

Yaoxue Xuebao

Volumn 36, Issue 6, 2001, Pages 423-426

  Wan, Sheng Biao ^a   Yi, Xiang ^a   Guo, Zong Ru ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Benzodiazepine; Comparative molecular field analysis (CoMFA); Farnesyl protein transferase (FPT)

Indexed keywords

2,3,4,5 TETRAHYDRO 1 (1H IMIDAZOL 4 YLMETHYL) 4 (2 BIPHENYLYLCARBONYL) 1H 1,4 BENZODIAZEPINE; 2,3,4,5-TETRAHYDRO-1-(1H-IMIDAZOL-4-YLMETHYL)-4-(2-BIPHENYLYLCARBONYL)-1H-1,4-BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; ENZYME INHIBITOR; IMIDAZOLE DERIVATIVE; P21(RAS) FARNESYL PROTEIN TRANSFERASE; P21(RAS) FARNESYL-PROTEIN TRANSFERASE; TRANSFERASE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; CONFORMATION; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

ALKYL AND ARYL TRANSFERASES; BENZODIAZEPINES; ENGLISH ABSTRACT; ENZYME INHIBITORS; IMIDAZOLES; MOLECULAR CONFORMATION; MOLECULAR STRUCTURE; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP; SUPPORT, NON-U.S. GOV'T;

EID: 0041830960     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Casey PJ, Solski PA, Der CJ, et al. p21 Ras is modified by a farnesyl isoprenoid [J]. Proc Natl Acad Sci USA, 1989,86(21):8323-8327.
2. Hancock JF, Magee AI, Chilad JE, et al. All ras proteins are polyisoprenylated but only some are palmitoylated [J]. Cell, 1989,57(7):1167-1177.
3. Schafer WR, Kim R, Sterne R, et al. Genetic and pharmacological suppression of oncogenic mutations in ras genes of yeast and humans [J]. Science, 1989,245:379 -385.
4. Ashby MN, King DS, Rine J. Endoproteolytic processing of a farnesylated peptide in vitro [J]. Proc Natl Acad Sci USA, 1992,89(10):4613-4617.
5. MaY-T, Rando RR. A microsomal endoprotease that specifically cleaves isoprenylated peptides [J]. Proc Natl Acad Sci USA , 1992,89(13):6275-6279.
6. Boyartchuk VL, Rine J. Roles of prenyl proteins in muturation of sccharomyces cerevisiae α-factor [J]. Genetics, 1998,150(1):95-101.
7. Otto JC, Kim E, Yong SG, et al. Cloning and characterization of a mammalian prenyl protein specific protease [J]. J Biol Chem, 1999, 274 (13):8379-8382.
8. Barbacid M. The ras oncogene [J]. Annu Rev Biochem, 1987,56:779-828.
9. Daniele M, Leonard, Judith S, et al. Ras farnesyltransferase inhibitors [J]. Drugs of the Future, 1999,24(10):1099-1106.
10. Grammer RD, Patterson DE, Bunce JD. Comparative molecular field analysis (CoMFA) 1: effect of shape on binding of steroids to carrieer proteins [J]. J Am Chem Soc, 1988,110(18):5959.
11. Huang CC, Casey PJ, Fierke CA. Evidence for a catalytic role of zinc in protein farnesyltransferase [J]. J Biol Chem, 1997,272(1):20-23.
12. Strickland CL, Windsor WT, Syto R, et al. Crystal Structure of farnesyl diphosphate analogue [J]. Biochemistry, 1998,37(47):16601-16611.
13. Charles ZD, Roberta B, Rajeev B, et al. Discovery and structure-activity relationships of imidazole-contain- ing tetrahydrobenzodiazepine inhibitors of farnesyltransferase [J]. J Med Chem, 1999,42(25):5241-53.